1DDE
 
 | | STRUCTURE OF THE DNAG CATALYTIC CORE | | 分子名称: | DNA PRIMASE, YTTRIUM ION | | 著者 | Keck, J.L, Roche, D.D, Lynch, A.S, Berger, J.M. | | 登録日 | 1999-11-09 | | 公開日 | 2000-04-07 | | 最終更新日 | 2024-02-07 | | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | | 主引用文献 | Structure of the RNA polymerase domain of E. coli primase.
Science, 287, 2000
|
|
1DD9
 | | STRUCTURE OF THE DNAG CATALYTIC CORE | | 分子名称: | DNA PRIMASE, STRONTIUM ION | | 著者 | Keck, J.L, Roche, D.D, Lynch, A.S, Berger, J.M. | | 登録日 | 1999-11-09 | | 公開日 | 2000-04-07 | | 最終更新日 | 2024-02-07 | | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | | 主引用文献 | Structure of the RNA polymerase domain of E. coli primase.
Science, 287, 2000
|
|
7T86
 | | Crystal Structure of Fab CR5133 / Phospho-SD Peptide Complex | | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody Fab CR5133 Heavy Chain, Antibody Fab CR5133 Light Chain, ... | | 著者 | Luo, J, Malia, T.J, Buckley, P.T. | | 登録日 | 2021-12-15 | | 公開日 | 2023-01-11 | | 最終更新日 | 2023-10-25 | | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | | 主引用文献 | Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Cell Host Microbe, 31, 2023
|
|
7T82
 | | Crystal Structure of LEUKOCIDIN E/CENTYRIN S26/FAB B438 | | 分子名称: | Antibody Fab Heavy Chain, Antibody Fab Light Chain, Centyrin S26, ... | | 著者 | Luo, J, Malia, T.J, Buckley, P.T. | | 登録日 | 2021-12-15 | | 公開日 | 2023-01-11 | | 最終更新日 | 2023-10-25 | | 実験手法 | X-RAY DIFFRACTION (3.5 Å) | | 主引用文献 | Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Cell Host Microbe, 31, 2023
|
|
7T87
 | | CRYSTAL STRUCTURE OF LEUKOCIDIN AB/CENTYRIN S17/FAB 214F COMPLEX | | 分子名称: | Antibody Fab B214 Heavy Chain, Antibody Fab B214 Light Chain, Centyrin S17, ... | | 著者 | Luo, J, Malia, T.J, Buckley, P.T. | | 登録日 | 2021-12-15 | | 公開日 | 2023-01-11 | | 最終更新日 | 2023-10-25 | | 実験手法 | X-RAY DIFFRACTION (3 Å) | | 主引用文献 | Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Cell Host Microbe, 31, 2023
|
|
7RWI
 | | Mycobacterium tuberculosis RNA polymerase sigma L holoenzyme open promoter complex containing TNP-2198 | | 分子名称: | (3aM,9S,10bP,14S,15R,16S,17R,18R,19R,20S,21S,25R)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadecanoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate, DNA-directed RNA polymerase subunit alpha, DNA-directed RNA polymerase subunit beta, ... | | 著者 | Molodtsov, V, Ebright, R.H. | | 登録日 | 2021-08-19 | | 公開日 | 2022-03-02 | | 最終更新日 | 2023-10-18 | | 実験手法 | X-RAY DIFFRACTION (3.7 Å) | | 主引用文献 | Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
J.Med.Chem., 65, 2022
|
|
